Single needle technology cleared by FDA; PMA supplement submitted for drug pump;

> Flowonix Medical submitted a PMA supplement to the FDA for new features to Prometra Implantable Pump System including "enhanced bolus delivery modes" for rapid intravenous delivery. Release

> NxStage Medical received FDA clearance for its OneSite single needle technology for dialysis treatment. Release

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.